ClinicalTrials.Veeva

Menu

Outcome of High Dose Vitamin D on Prognosis of Sepsis Requiring Mechanical Ventilation

A

Ain Shams University

Status and phase

Completed
Phase 4

Conditions

Sepsis

Treatments

Drug: Vitamin D3 tablets
Drug: Vitamin D tablets

Study type

Interventional

Funder types

Other

Identifiers

NCT05244018
FMASU MS 47/ 2022

Details and patient eligibility

About

There is a high prevalence of vitamin D deficiency in the critically ill patient population, with approximately 60% of patients found to be vitamin D deficient, (25(OH)D concentrations <20 ng/mL) and an additional 30% of patients being vitamin D insufficient, (25(OH)D = 20-30 ng/mL).Approximately 80% of sepsis/septic shock patients experience respiratory failure and require mechanical ventilation. Furthermore, several studies document that vitamin D deficiency could be associated with poor outcomes in critically ill patient.

Enrollment

80 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Diagnosed with sepsis and required mechanical ventilation (MV) within 24 hours from ICU admission.
  • Expected to require mechanical ventilation for at least 72 hours after study entry.

Exclusion criteria

  • Age <18 years.
  • inability to obtain informed consent from the patient and/or legally authorized representative.
  • BMI> 40.
  • Pregnant or breastfeeding.
  • Chronic kidney diseases
  • Pancreatitis.
  • Hepatic insufficiency
  • Cases with coagulopathy
  • Moribund and not expected to survive 96 hours.
  • Ongoing shock
  • History of therapy with high dose vitamin D3 within previous 6 months.
  • History of disorders associated with hypercalcemia
  • Cancer as the cause of sepsis.
  • Subjects undergoing chemotherapy.
  • Immune compromised patients.
  • Pneumonia developed < 48 hours following intubation.
  • Patients with history of aspiration before intubation.
  • known allergy to vitamin D.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

80 participants in 2 patient groups

Group 1(Treatment group)
Active Comparator group
Treatment:
Drug: Vitamin D3 tablets
Group 2(Control group)
Active Comparator group
Treatment:
Drug: Vitamin D tablets

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems